Weight changes after stopping a weight-loss drug
Part of Hormones & metabolism clinical trials.
This study looks at what happens to your weight when you stop taking a weight-loss drug (called an incretin-mimetic, like Ozempic or Wegovy). It may help find ways to keep weight off after stopping the medication.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are currently prescribed an incretin-mimetic drug for weight loss.
- Your insurance coverage for this drug is going to lapse (end).
- You do not have diabetes (type 1 or type 2).
- You are not pregnant or planning to become pregnant in the next 6 months.
- You are not a current smoker and do not use recreational drugs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at what happens to your body and weight when you stop taking semaglutide (Wegovy/Ozempic) after losing at least 10% of your starting weight. The goal is to understand how your metabolism and heart health change once the medication is paused.
This trial tests whether a daily probiotic supplement can help people maintain their weight after they stop taking a GLP-1 medication (like Ozempic or Wegovy). It aims to see if the probiotic helps keep the weight off.
This study looks at how starting a GLP-1 medication (like Wegovy or Ozempic) changes your food choices and eating habits. It may help you understand if these medicines work for weight loss.
This study looks at what happens when people taking a GLP-1 medication (like Ozempic) either stop or continue it after weight loss surgery. The goal is to learn whether staying on the medicine helps with long-term weight control.
This study follows people who recently stopped taking a GLP-1 medication to see how their eating habits, daily routines, and weight change over time. It aims to learn how to better support people after they stop, helping them maintain a healthy weight.
This study tests a 6-month behavioral program to help people keep off the weight they lost using GLP-1 or other weight-loss medications after they stop taking those medications. The program includes a 10-week foundational course, virtual sessions, and support to help you maintain your weight loss.
Hear when a new Obesity and Obesity-related Medical Conditions trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.